Napredna pretraga

Pregled bibliografske jedinice broj: 135971

Association of coagulation and fibrinolysis gene polymorphisms with coronary artery disease (The Zagreb cohort)


Coen, Desiree; Ferenčak, Goran; Gršković, Branka; Cheng, Suzanne; Šesto, Mihajlo; Skodlar, Jasna; Stavljenić Rukavina, Ana
Association of coagulation and fibrinolysis gene polymorphisms with coronary artery disease (The Zagreb cohort) // Clinical Chemistry and Laboratory Medicine, 41 (2003) (podatak o recenziji nije dostupan, kongresno priopcenje, znanstveni)


Naslov
Association of coagulation and fibrinolysis gene polymorphisms with coronary artery disease (The Zagreb cohort)

Autori
Coen, Desiree ; Ferenčak, Goran ; Gršković, Branka ; Cheng, Suzanne ; Šesto, Mihajlo ; Skodlar, Jasna ; Stavljenić Rukavina, Ana

Izvornik
Clinical Chemistry and Laboratory Medicine (0300-5577) 41 (2003);

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, kongresno priopcenje, znanstveni

Ključne riječi
Coagulation; fibrinolysis gene polymorphism; coronary artery disease

Sažetak
Coronary artery disease (CAD) is a multifactorial disease influenced by both genetic and environmental determinants. Since coagulation activation plays a key role in thrombus formation, genetic mutations of proteins involved in coagulation and fibrinolysis may have a role in the pathogenesis CAD. The aim of our study was to investigate the association between the risk of CAD and genetic factors thought to be associated with an increased tendency to thrombosis: polymorphisms 4G/5G and G11053T of PAI-1 gene, G-455A of fibrinogen gene, G10976A and &#8211; 323 0/10-bp of factor VII gene, G1691A of factor V gene, and G20210A of prothrombin gene. We performed a case-control study evaluating 479 patients with angiographically documented CAD (>50% stenosis of at least one coronary artery) and 200 controls without CAD (<10% stenosis). The polymorpisms were genotyped using a multilocus genotyping assay for candidate markers of cardiovascular disease risk (Roche Molecular Systems Inc, USA). After adjustment for other risk factors the following odds ratios (OR) and confidence intervals (95% CI) were obtained (dominant and recessive models): PAI-1 4G/4G and 11053 TT (OR 1.24 and 0.84, 95% CI 0.84 to 1.83 and 0.56 to 1.25, respectively), fibrinogen &#8211; 455AA (OR 1.05, 95% CI 0.75 to 1.50), factor VII 10976AA and &#8211; 32310/10-bp (OR 0.58 and 0.59, 95% CI 0.11 to 2.97 and 0.15 to 2.25, respectively). In conclusion, the studied polymorphisms were not associated with CAD in this cohort.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Citiraj ovu publikaciju

Coen, Desiree; Ferenčak, Goran; Gršković, Branka; Cheng, Suzanne; Šesto, Mihajlo; Skodlar, Jasna; Stavljenić Rukavina, Ana
Association of coagulation and fibrinolysis gene polymorphisms with coronary artery disease (The Zagreb cohort) // Clinical Chemistry and Laboratory Medicine, 41 (2003) (podatak o recenziji nije dostupan, kongresno priopcenje, znanstveni)
Coen, D., Ferenčak, G., Gršković, B., Cheng, S., Šesto, M., Skodlar, J. & Stavljenić Rukavina, A. (2003) Association of coagulation and fibrinolysis gene polymorphisms with coronary artery disease (The Zagreb cohort). Clinical Chemistry and Laboratory Medicine, 41.
@article{article, year = {2003}, pages = {S319}, keywords = {coagulation, fibrinolysis gene polymorphism, coronary artery disease}, journal = {Clinical Chemistry and Laboratory Medicine}, volume = {41}, issn = {0300-5577}, title = {Association of coagulation and fibrinolysis gene polymorphisms with coronary artery disease (The Zagreb cohort)}, keyword = {coagulation, fibrinolysis gene polymorphism, coronary artery disease} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE